Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-13 · accession 0001628280-25-005864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-13 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $9.15 | -1,562 | 28.2K | -5% | -$14.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | S | D | 1,562 | $9.15 | 28,189 | D | — | — | (F2) Reflects ownership after acquisition by the reporting person on November 29, 2024 of 1,312 shares of common stock pursuant to the Issuer's employee stock purchase program. |